Depressive Symptoms in Children and Adolescents with Chronic Physical Illness
Depressive Symptoms in Children and Adolescents with Chronic Physical Illness
Depressive Symptoms in Children and Adolescents with Chronic Physical Illness
Permalink:
In the United States, the number of children and adoles-
cents with chronic health conditions has increased dramat-
ically in the past four decades (Perrin, Bloom, &
Gortmaker, 2007). Although results from epidemiological
studies differ considerably, an overview of articles found
that, on average, 15% of children and adolescents have a
chronic health condition (van der Lee, Mokkink,
Grootenhuis, Heymans, & Offringa, 2007).
Chronic illness is a risk factor for psychological prob-
lems, such as depressive symptoms (e.g., Bennett, 1994).
For example, the presence of physical symptoms, such as
pain and fatigue, combined with the need for disease man-
agement regimes, are likely to interfere with many aspects
of daily life, such as regular school attendance and main-
taining peer relations, and may cause frustration (e.g.,
Suris, Michaud, & Viner, 2004). Children with chronic
illness may feel different from his peers and experience
peer rejection, which may have detrimental effects on
their self-concept (e.g., Sandstrom & Schanberg, 2004).
In addition, chronic illnesses may foster inappropriate
parental attitudes and behaviors, ranging from overprotec-
tion to rejection, which may impair psychological
well-being (e.g., Holmbeck et al., 2002). In some cases,
poor prognosis may cause feelings of helplessness and
hopelessness. Finally, side effects of treatments may
cause psychological distress (e.g., Miller et al., 2008).
A meta-analysis by Bennett (1994) on 60 statistical
effects from 46 studies found that children and adolescents
with chronic medical problems have elevated levels of de-
pressive symptoms, but differences with test norms or
healthy control groups were small (mean d¼ .27 SD units). Because (a) the number of studies has increased
considerably since this meta-analysis, (b) the effects of
chronic illness on depressive symptoms may have changed
over time, and (c) the previous meta-analysis could not test
for moderating effects of many study characteristics, the
Journal of Pediatric Psychology 36(4) pp. 375–384, 2011 doi:10.1093/jpepsy/jsq104
Advance Access publication November 18, 2010 Journal of Pediatric Psychology vol. 36 no. 4 � The Author 2010. Published by Oxford University Press on behalf of the Society of Pediatric Psychology.
All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
goal of the present study was to provide an updated
meta-analysis on the association between chronic physical
illness and depressive symptoms in children and
adolescents.
Depressive symptoms have to be distinguished from a
depressive disorder, such as major depression. Rating
scales assess depressive symptoms as a continuous vari-
able, and scores above defined cutoffs on valid scales
would imply a depressive disorder. However, depression
diagnosis is based on a clinical interview, and a number
of symptoms have to be present during a specified time
period (Emslie & Mayers, 1999). Because about 90% of the
available studies with chronically ill children used depres-
sion rating scales rather than clinical diagnoses, the present
meta-analysis focuses on depressive symptoms.
Research Questions
In the first research question we ask whether children and
adolescents with chronic physical illnesses have elevated
levels of depressive symptoms, and whether this would
differ between illnesses. Some authors have argued that
the nature of the child’s disorder is not important in de-
termining its psychological consequences, because chil-
dren with chronic physical disorders face common life
experiences and problems based on generic dimensions
of their conditions, rather than on idiosyncratic character-
istics of any specific disease entity (e.g., Stein & Jessop,
1982). Other authors have suggested that certain illness
characteristics or parameters may be more related to de-
pressive symptoms, such as neurologically related illnesses
(e.g., epilepsy; Plioplys, 2003), characteristics of illnesses
that have social implications (e.g., cosmetic effects, e.g.,
cleft lip; De Sousa, Devare, & Ghanshani, 2009), and
chronic pain (Eccleston, Crombez, Scotford, Clinch, &
Connell, 2004). Bennett (1994) reported moderate effect
sizes for asthma (d¼ .54) and sickle cell disease (d¼ .48), a small effect size for diabetes (d¼ .22), and no elevated levels of depressive symptoms in young people with cancer
(d¼ .00) and cystic fibrosis (d¼ –.04). However, due to the small number of studies per type of illness
(N¼ 4–13), effect sizes were not tested to see if they dif- fered significantly from zero or if illnesses differed from one
another.
In the second research question we analyze whether
the effect sizes would differ by other study characteristics.
Age
On the one hand, depressive symptoms are more common
in adolescence than in childhood, and adolescents may be
confronted with more illness-related stressors than chil-
dren (e.g., when chronic illnesses hinder the development
of peer groups and intimate relationships; Suris et al.,
2004). On the other hand, adolescents might also have
better coping abilities (e.g., because of higher cognitive
abilities; Skinner & Zimmer-Gembeck, 2007). Thus, aver-
age age differences in the association between chronic ill-
ness and depressive symptoms are probably small. Bennett
(1994) reported that age was generally unrelated to depres-
sive symptoms, but he did not provide results from a
statistical test of age differences.
Gender
On average, female adolescents are more likely than males
to react to stressors with depressive symptoms (Piccinelli
& Wilkinson, 2000), which could lead to stronger effects
of chronic illness on depressive symptoms. Bennett (1994)
reported that the results of individual studies were incon-
sistent but he did not formally test for gender differences.
Race/Ethnicity
Because it is less clear whether race/ethnicity would mod-
erate the size of between-group differences, we did not
state a hypothesis.
Country
Because young people from industrialized, developed
countries may have better access to health care than their
peers from developing countries, we expected finding
lower between-group differences in depressive symptoms
in developed countries.
Year of Publication
Progress in the treatment of many diseases (e.g., Bleyer,
2002) and the development of services for young people
with chronic illness may lead to lower between-group
differences in more recent studies.
Rater and Assessment Methods
Bennett (1994) found higher between-group differences in
parent-rated depressive symptoms (d¼ 0.58) than in self-rated depressive symptoms (d¼ 0.02), which may either indicate that young patients tend to underreport
their psychological symptoms or that parents underesti-
mate their children’s ability to adapt to their illness.
Differences between raters were also expected to lead to
higher levels of depressive symptoms in young people with
chronic illnesses in studies that used parent ratings as a
measure of depressive symptoms (e.g., the Affective
Problems scale of the Child Behavior Checklist (CBCL);
376 Pinquart and Shen
Achenbach, Dumenci, & Rescorla, 2003) than in studies
that used self-reports of the child.
Duration of Illness
A longer duration of the disease gives more time for
psychological adaptation, but may also lead to an accumu-
lation of negative illness-related consequences, such as the
effect of repeated school absence on grades. Thus, we did
not state a specific hypothesis.
Study Quality
Associations of chronic illness with depressive symptoms
may be stronger in clinical convenience samples than in
representative community-based samples, because clinical
samples may overrepresent highly distressed young people
seeking treatment for their chronic disease. Similarly, the
size of between-group differences in depressive symptoms
may vary between studies that used groups matched on
sociodemographic variables and studies that did not con-
trol for these between-group differences, because the lack
of control for demographic variables may cause unsyste-
matic bias rather than a general overestimation or under-
estimation of between-group differences in depressive
symptoms.
Target of Comparison
Finally, between-group differences may be larger in studies
that compared children with chronic illnesses to healthy
peers than in studies that compared depressive symptoms
of chronically ill children to test norms, because the norm
population probably includes some children with chronic
illnesses. In fact, Bennett (1994) found such a difference
(d¼ 0.67 vs. d¼ 0.02).
Methods Sample
Studies were identified from the literature through elec-
tronic databases [PSYCINFO, MEDLINE, Google Scholar,
PSNYDEX (an electronic data base of psychological litera-
ture from German-speaking countries)—search terms:
(chronic illness or disability or aids or arthritis or asthma
or cancer or cleft or chronic fatigue syndrome or cystic
fibrosis or diabetes or fibromyalgia or hemophilia or hear-
ing impairment or HIV or epilepsy or inflammatory bowel
disease or migraine or rheumatism or sickle cell or spina
bifida or visual impairment) and (children or adolescents
or adolescence) and (depression or depressive or mental
health or psychological health)], and cross-referencing.
Criteria for inclusion of studies in the present
meta-analysis were:
(a) the studies have been published before September,
2010,
(b) they compared the levels of depressive symptoms
or the frequency of depression diagnoses between
children and adolescents with chronic physical ill-
ness and their healthy peers or test norms, or they
provided sufficient information for a comparison
with established normative data (e.g., by reporting
standardized T-scores),
(c) mean age of participants �18 years, and (d) standardized between-group differences in depres-
sive symptoms were reported or could be
computed.
Documentation of physician diagnosis within each study
was not a requirement, because of the need to include
broad-based survey studies for which medical documenta-
tion might not be available. However, studies were excluded
if they focused on young people with chronic illnesses that
have been referred to psychological services due to depres-
sive symptoms, or if sufficient information for computing
effect sizes was not reported. In order to include studies
from different regions around the world, we also did not
limit the included studies to those written in English.
Available unpublished studies were also included.
Approximately 25% of the total number of studies
surveyed were eliminated, mainly because they did not
assess depressive symptoms or depression diagnosis
(14%), provided insufficient information about the effect
sizes (4%), did not exclusively focus on children and ado-
lescents with chronic physical illnesses (3%), had an aver-
age age of participants >18 years (1%), duplicated results
of previously published studies (1%), or were not available
via interlibrary loan (1%). After the exclusion of such stud-
ies, we were able to include 340 studies in the
meta-analysis that provided results for 450 subsamples.
The studies included are listed in the Appendix S1 (see
the Supplementary Data).
We entered the number of patients and control group
members, mean age, percentage of girls and of members of
ethnic minorities, the country of data collection, year of
publication, type of illness, duration of illness, the sam-
pling procedure (1¼ probability samples, 0¼ convenience samples), the use of a control group (0¼ yes, 1¼ compar- ison with test norms), equivalence of patients and control
group (1¼ yes, 2¼ not tested, 3¼ no), the rater of depres- sive symptoms (1¼ child, 2¼ parent, 3¼ teacher, 4¼ cli- nician), the measurement of the variables, and the
standardized size of between-group differences in
Depression and Chronic Illness 377
depressive symptoms. If between-group differences were
provided for several subgroups within the same publication
(e.g., for different illnesses), we entered them separately in
our analysis instead of entering the global association.
If data from more than one rater were collected, we entered
the effect sizes separately because we were interested in
whether the effect size would vary by the source of infor-
mation. However, in order to avoid a disproportional
weight of these studies, we adjusted the weights of the
individual effect sizes so that the sum of the weights of
the effect sizes was equal to the weight of the study if
only one effect size had been reported (Lipsey & Wilson,
2001). Based on one third of the coded studies, a mean
inter-rater reliability of 93% (range 86–100%) was
established.
Measures
Depressive symptoms were most often assessed with the
Child Depression Inventory (CDI; Kovacs, 1992; 203 sam-
ples), structured clinical interviews (46 samples), the Beck
Depression Inventory/Beck Youth Inventory (Beck, Beck,
& Jolly, 2001; 41 samples), the Behavior Assessment
System for Children (Reynolds & Kamphaus, 2004;
39 samples), the Affective Problems scale of the CBCL
(13 samples), and the depression scale of the Minnesota
Multiphasic Personality Inventory (MMPI) (Tellegen et al.,
2003; 10 samples).
Information from the World Bank (2010) was used for
coding countries as developed or developing/threshold
countries.
Statistical Integration of the Findings
Calculations for the meta-analysis were performed in six
steps, using random-effects models and the method of mo-
ments (for computations, see Lipsey & Wilson, 2001).
1. We computed effect sizes d for each study as the
difference in depressive symptoms between the
sample with chronic illness and the control
sample divided by the pooled SD. If the authors
provided only test scores for children and adoles-
cents with chronic illness, we used the norms
from the test manual for comparison. However,
because Twenge and Nolen-Hoeksema (2002) pro-
vided norms for the CDI based on a much larger
sample than the original manual (Kovacs, 1992),
we used the norms by Twenge and
Nolen-Hoeksema (2002). Outliers that were more
than two SD from the mean of the effect sizes
were recoded to the value at two SD (Lipsey &
Wilson, 2001).
2. Effect size estimates were adjusted for bias due to
overestimation of the population effect size in
small samples.
3. Weighted mean effect sizes and 95% confidence
intervals (95% CIs) were computed. The signifi-
cance of the mean was tested by dividing the
weighted mean effect size by the SE of the mean.
To interpret the practical significance of the re-
sults, we used the Binomial Effect Size Display
(BESD; Rosenthal & Rubin, 1982) and Cohen’s
criteria (Cohen, 1988). According to Cohen, differ-
ences of d� .8 are interpreted as large, of d¼ .50–.79 as medium, and of d¼ .20–.49 as small.
4. For testing whether the results may be influenced
by publication bias (a trend for nonsignificant re-
sults not being published), we used the ‘‘trim and
fill’’ algorithm (Duval & Tweedie, 2000), which
estimates an adjusted effect size in the presence of
publication bias.
5. Homogeneity of effect sizes was computed by use
of the Q statistic.
6. In order to test the influence of moderator vari-
ables, we used an analogue of analysis of variance
and weighted ordinary least squares regression
analyses.
Results
Data from 33,047 children and adolescents with chronic
illnesses were included. The largest subgroups had asthma
(N¼ 9,274), diabetes (N¼ 4,058), cancer (N¼ 3,400), mi- graine or tension-type head ache (N¼ 2,300), and epilepsy (N¼ 2,096). The participants had a mean age of 12.6 years (SD¼ 2.6 years); 50.2% of them were girls and 32.5% were members of ethnic minorities.
On average, children and adolescents with chronic
physical illnesses had higher levels of depressive symptoms
than their healthy peers—a small to very small effect
(Table I). According to the BESD, 54.8% of children with
chronic illnesses and 45.2% of their healthy peers would
show depressive symptoms above the median. The
trim-and-fill algorithm did not find any evidence for a
file-drawer problem, and the original effect size remained
unchanged after applying this procedure.
We computed separate effects in cases where at least
five studies were available for a particular chronic disease.
Separate effect sizes could be computed for 16 illnesses.
Strongest between-group differences were found for
chronic fatigue syndrome, fibromyalgia, migraine/tension
378 Pinquart and Shen


Leave a Reply
Want to join the discussion?Feel free to contribute!